Which pulse sequence is optimal for myo-inositol detection at 3T?

NMR in Biomedicine

Volumn 22, Issue 4, 2009, Pages 426-435

  Hancu, Ileana ^a  

^a GE GLOBAL RESEARCH   (United States)

Author keywords

3T; 1H MRS; Monte Carlo simulations; Myo inositol

Indexed keywords

3T; 1H MRS; CLINICAL SCANNERS; IN-VIVO; MONTE CARLO SIMULATIONS; MYO-INOSITOL; PATHOLOGICAL CONDITIONS; PULSE SEQUENCE; QUANTUM FILTERS; SHORT-TE PRESS; SINGLE QUANTUM;

ACOUSTIC INTENSITY; ALCOHOLS; COMPUTER SIMULATION LANGUAGES; MONTE CARLO METHODS; OPTICAL RESOLVING POWER; PRESSES (MACHINE TOOLS); SIGNAL TO NOISE RATIO; SUGARS;

OPTIMIZATION;

INOSITOL;

ACCURACY; ARTICLE; IMAGING SYSTEM; MEASUREMENT; NUCLEAR MAGNETIC RESONANCE; POINT RESOLVED SPECTROSCOPY; PRIORITY JOURNAL; RADIOFREQUENCY; SIGNAL NOISE RATIO; SIMULATION; SPECTROSCOPY; STIMULATED ECHO ACQUISITION MODE; THREE DIMENSIONAL IMAGING; ADULT; BRAIN; COMPUTER SIMULATION; HUMAN; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; REPRODUCIBILITY; TIME;

ADULT; BRAIN; COMPUTER SIMULATION; HUMANS; INOSITOL; MAGNETIC RESONANCE IMAGING; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 67649198915     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1353     Document Type: Article

References (38)

1. Ross BD. Biochemical considerations in 1H spectroscopy. Glutamate and glutamine; myo-inositol and related metabolites. NMR Biomed. 1991; 4(2): 59-63.
2. Brand A, Richter-Landsberg C, Leibfritz D. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev. Neurosci. 1993; 15: 289-298.
3. Fernando KT, McLean MA, Chard DT, MacManus DG, Dalton CM, Miszkiel KA, Gordon RM, Plant GT, Thompson AJ, Miller DH. Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis. Brain 2004; 127(Pt 6): 1361-1369.
4. Ross BD, Ernst T, Kreis R, Haseler LJ, Bayer S, Danielsen E, Bluml S, Shonk T, Mandigo JC, Caton W, Clark C, Jensen SW, Lehman NL, Arcinue E, Pudenz R, Shelden CH. 1H MRS in acute traumatic brain injury. J. Magn. Reson. Imaging 1998; 8(4): 829-840.
5. Kantarci K, Jack CR, Jr., Xu YC, Campeau NG, O'Brien PC, Smith GE, Ivnik RJ, Boeve BF, Kokmen E, Tangalos EG, Petersen RC. Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: a 1H MRS study. Neurology 2000; 55(2): 210-217.
6. Govindaraju V, Young K, Maudsley AA. Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed. 2000; 13(3): 129-153.
7. 1H-MRS in vivo. Magn. Reson. Med. 1999; 41(1): 193-197.
8. Okada T, Sakamoto S, Nakamoto Y, Kohara N, Senda M. Reproducibility of magnetic resonance spectroscopy in correlation with signal-to-noise ratio. Psychiatry Res. 2007; 156(2): 169-174.
9. 1H MRS; optimizing echo time and voxel placement. Proc Int Soc Magn Res Med, Toronto. 2003; 437.
10. Kim H, Wild JM, Allen PS. Strategy for the spectral filtering of myo-inositol and other strongly coupled spins. Magn. Reson. Med. 2004; 51(2): 263-272.
11. Hennig J, Thiel T, Speck O. Improved sensitivity to overlapping multiplet signals in in vivo proton spectroscopy using a multiecho volume selective (CPRESS) experiment. Magn. Reson. Med. 1997; 37(6): 816-820.
12. Sailasuta N, Hurd R, Cunningham C, Vigneron DB, Nelson SJ, Pauly J. A novel approach for reducing chemical shift registration error at 3T: short TE CPRESS. Proc Int Soc Magn Res Med, Kyoto. 2004; 2297.
13. Zhong K, Ernst T. Localized in vivo human 1H MRS at very short echo times. Magn. Reson. Med. 2004; 52(4): 898-901.
14. Kim H, Thompson RB, Hanstock CC, Allen PS. Variability of metabolite yield using STEAM or PRESS sequences in vivo at 3.0 T, illustrated with myo-inositol. Magn. Reson. Med. 2005; 53(4): 760-769.
15. Smith S, Levante T, Meier B, Ernst R. Computer simulations in magnetic resonance. An object-oriented programming approach. J. Magn. Reson. Series A 1994; 106(1): 75-105.
16. 1H metabolite resonances at long TE. Magn. Reson. Med. 2005; 53(6): 1283-1287.
17. Trabesinger AH, Mueller DC, Boesiger P. Single-quantum coherence filter for strongly coupled spin systems for localized (1)H NMR spectroscopy. J. Magn. Reson. 2000; 145(2): 237-245.
18. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn. Reson. Med. 1993; 30(6): 672-679.
19. Young K, Matson GB, Govindaraju V, Maudsley AA. Spectral simulations incorporating gradient coherence selection. J. Magn. Reson. 1999; 140(1): 146-152.
20. Pauly J, Le Roux P, Nishimura D, Macovski A. Parameter relations for the Shinnar-Le Roux selective excitation pulse design algorithm [NMR imaging]. IEEE Trans. Med. Imaging 1991; 10(1): 53-65.
21. Pickup S, Ding X. Pulses with fixed magnitude and variable phase response profiles. Magn. Reson. Med. 1995; 33(5): 648-655.
22. Seeger U, Klose U, Seitz D, Nagele T, Lutz O, Grodd W. Proton spectroscopy of human brain with very short echo time using high gradient amplitudes. Magn. Reson. Imaging 1998; 16(1): 55-62.
23. 1H metabolite relaxation times at 3.0 tesla: measurements of T1 and T2 values in normal brain and determination of regional differences in transverse relaxation. J. Magn. Reson. Imaging 2004; 19(5): 537-545.
24. Cudalbu C, Cavassila S, Rabeson H, van Ormondt D, Graveron-Demilly D. Influence of measured and simulated basis sets on metabolite concentration estimates. NMR Biomed. 2008; 21(6): 627-636.
25. Cavassila S, Deval S, Huegen C, van Ormondt D, Graveron-Demilly D. Cramer-Rao bounds: an evaluation tool for quantitation. NMR Biomed. 2001; 14(4): 278-283.
26. Bartha R. Effect of signal-to-noise ratio and spectral linewidth on metabolite quantification at 4 T. NMR Biomed. 2007; 20(5): 512-521.
27. Thomas MA, Hattori N, Umeda M, Sawada T, Naruse S. Evaluation of two-dimensional L-COSY and JPRESS using a 3 T MRI scanner: from phantoms to human brain in vivo. NMR Biomed. 2003; 16(5): 245-251.
28. Ernst R, Bodenhausen G, Wokaun A. Principles of nuclear magnetic resonance in one and two dimensions; 1988.
29. Schulte RF, Boesiger P. ProFit: two-dimensional prior-knowledge fitting of J-resolved spectra. NMR Biomed. 2006; 19(2): 255-263.
30. Elderkin-Thompson V, Thomas MA, Binesh N, Mintz J, Haroon E, Dunkin JJ, Kumar A. Brain metabolites and cognitive function among older depressed and healthy individuals using 2D MR spectroscopy. Neuropsychopharmacology 2004; 29(12): 2251-2257.
31. Binesh N, Yue K, Fairbanks L, Thomas MA. Reproducibility of localized 2D correlated MR spectroscopy. Magn. Reson. Med. 2002; 48(6): 942-948.
32. Sandgren N, Stoica P, Frigo FJ. Area-selective signal parameter estimation for two-dimensional MR spectroscopy data. J. Magn. Reson. 2006; 183(1): 50-59.
33. Prescot AP, de BFB,Wang L, Brown J, Jensen JE, Kaufman MJ, Renshaw PF. In vivo detection of brain glycine with echo-time-averaged (1)H magnetic resonance spectroscopy at 4.0 T. Magn. Reson. Med. 2006; 55(3): 681-686.
34. 1H-MRS in vivo at 3.0 T. Magn. Reson. Med. 2008; 59(1): 59-64.
35. Yeh IB, Xu M, Ng WH, Ye J, Yang D, Lim CC. Central neurocytoma: typical magnetic resonance spectroscopy findings and atypical ventricular dissemination. Magn. Reson. Imaging 2008; 26(1): 59-64.
36. 1H magnetic resonance spectroscopic measurement of brain glycine levels in nonketotic hyperglycinemia. J. Neuroimaging 2001; 11(2): 209-211.
37. Allerhand A, Gutowsky HS, Spin-echo studies of chemical exchange. II. Closed formulas for two sites. J. Chem. Phys. 1965; 42: 1587-1599.
38. Thompson RB, Allen PS. Sources of variability in the response of coupled spins to the PRESS sequence and their potential impact on metabolite quantification. Magn. Reson. Med. 1999,41(6):1162-1169.